Your browser doesn't support javascript.
loading
Impact of pretreatment anemia on upfront abiraterone acetate therapy for metastatic hormone-sensitive prostate cancer: a multicenter retrospective study.
Okamoto, Teppei; Noro, Daisuke; Hatakeyama, Shingo; Narita, Shintaro; Mitsuzuka, Koji; Sakurai, Toshihiko; Kawamura, Sadafumi; Hoshi, Senji; Shimoda, Jiro; Tanaka, Toshikazu; Kawaguchi, Toshiaki; Ishidoya, Shigeto; Ito, Akihiro; Tsuchiya, Norihiko; Habuchi, Tomonori; Ohyama, Chikara.
Afiliação
  • Okamoto T; Department of Urology, Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, 5 Zaifu-chou, Hirosaki, 036-8562, Japan.
  • Noro D; Department of Urology, Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, 5 Zaifu-chou, Hirosaki, 036-8562, Japan.
  • Hatakeyama S; Department of Urology, Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, 5 Zaifu-chou, Hirosaki, 036-8562, Japan. shingoh@hirosaki-u.ac.jp.
  • Narita S; Department of Urology, Akita University School of Medicine, 1-1-1, Hondo, Akita, 010-8543, Japan.
  • Mitsuzuka K; Department of Urology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Sakurai T; Department of Urology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, Yamagata, 990-9585, Japan.
  • Kawamura S; Department of Urology, Miyagi Cancer Center, 47-1, Nodayama, Shiote, Aijima, Natori, Miyagi, 981-1293, Japan.
  • Hoshi S; Department of Urology, Yamagata Prefectural Central Hospital, 1800, Aoyanagi, Yamagata, 990-2292, Japan.
  • Shimoda J; Department of Urology, Iwate Prefectural Isawa Hospital, 61, Ryugabaab, Mizusawa-ku, Oshu, Iwate, 023-0864, Japan.
  • Tanaka T; Department of Urology, Aomori Prefectural Central Hospital, 2-1-1, Higashi-tsukurimichi, Aomori, Aomori, 030-8553, Japan.
  • Kawaguchi T; Department of Urology, Aomori Prefectural Central Hospital, 2-1-1, Higashi-tsukurimichi, Aomori, Aomori, 030-8553, Japan.
  • Ishidoya S; Department of Urology, Sendai City Hospital, 1-1-1, Nagamachi, Asuto, Taihaku-ku, Sendai, Miyagi, 982-8502, Japan.
  • Ito A; Department of Urology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.
  • Tsuchiya N; Department of Urology, Yamagata University School of Medicine, 2-2-2 Iida-Nishi, Yamagata, Yamagata, 990-9585, Japan.
  • Habuchi T; Department of Urology, Akita University School of Medicine, 1-1-1, Hondo, Akita, 010-8543, Japan.
  • Ohyama C; Department of Urology, Department of Advanced Blood Purification Therapy, Hirosaki University Graduate School of Medicine, 5 Zaifu-chou, Hirosaki, 036-8562, Japan.
BMC Cancer ; 21(1): 605, 2021 May 25.
Article em En | MEDLINE | ID: mdl-34034691

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Síntese de Esteroides / Acetato de Abiraterona / Anemia Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores da Síntese de Esteroides / Acetato de Abiraterona / Anemia Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão